The future standard
for brucellosis vaccines
Brucellosis can break out at any time:
even here in Europe!
Brucella is one of the major causes of diseases in LatAm, Asia, and Africa, with an average prevalence of 16%.
This devastating disease propagates very easily among mammals, which infect humans; Main transmitters are Cattle and Sheep and Coats.
It is a dangerous and chronic disease, very difficult to treat;
- Consequences: Abortions, sterility, productivity losses and death;
- Human cases estimated to be up to 12,500,000 annually;
- Annual losses go from €535m in LatAm, to €2.0 bn in Africa and up to €3.03bn in India
There are classical vaccines in the markets for over 60 years, but they are inadequate to eradicate the disease;
They are unsafe, being limited its use to young animals and being therefore inadequate for mass vaccination.
Another major problem is known as DIVA problem: Differentiation between infected and Vaccinated Animals. This problem may affetct 20% of the herd, which will habitually end up in preventive culling, causing dramatic troubles and costs.